CHO-K1 Cynomolgus CD8 Cell

CHO-K1 Cynomolgus CD8 Cell

Cat. No: RQP74489

Size: 1 vial of frozen cells (>1E6 per vial in 1 mL)

Unit Price: Contact For Pricing

Contact us
Product Info
Description
Assay Data
Cell Culture
Cat. No RQP74489
Product Name CHO-K1 Cynomolgus CD8 Cell
Product Type Expression Cell line
Culture Properties Adherent
Stability 32passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)
Mycoplasma Status Negative
Culture Medium F12K+10%FBS+5 μg/ml Blasticidin
Freeze Medium 90% FBS+10% DMSO
Storage Conditions Liquid nitrogen immediately upon delivery
Application Binding Assay,FACS

 

 

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.

  

The CD8 molecule, encoded by the CD8 gene, is a critical co-receptor on the surface of T cells. Primarily expressed on cytotoxic T lymphocytes (CTLs), it exists either as a heterodimer formed by disulfide-linked α (CD8α) and β (CD8β) subunits or as an α-α homodimer. Functioning as an accessory molecule to the T-cell receptor (TCR), CD8 binds to major histocompatibility complex class I (MHC I) molecules via its extracellular domain; this interaction enhances the sensitivity of the TCR to antigen-MHC complexes, thereby activating the cytotoxic function of T cells to precisely eliminate virus-infected or tumor cells.

The CD8 gene is located on human chromosome 2 (2p12) and comprises multiple exons, generating distinct mRNA isoforms through alternative splicing. Its expression is regulated by factors such as the transcription factor Runx3; it plays a pivotal role during the positive selection stage of thymic T-cell development, ensuring that T cells acquire the ability to recognize self-MHC molecules. Clinically, CD8+ T cells serve as core effector cells in tumor immunity; their infiltration density positively correlates with patient prognosis in various cancers (such as melanoma and colorectal cancer), and they are key targets for immune checkpoint inhibitors (e.g., anti-PD-1 therapies).

Figure 1. Recombinant Cyno CD8 CHO stably expressing Cyno CD8a & CD8b.

 

Cell Resuscitation
1)Rapidly thaw the frozen cells in a 37 °C water bath for approximately 60 seconds. Once thawed (which may take slightly less or more than 60 seconds), immediately transfer the cell suspension from the cryovial into a 15 mL centrifuge tube containing 10 mL of pre-warmed  CHO-K1 Cynomolgus CD8 Cell complete culture medium.
2)Centrifuge cells at 1000 rpm for 5 min to remove medium, then resuspend cells in 5 mL of pre-warmed complete medium.
3)Transfer the cell suspension into a T25 culture flask and incubate at 37 °C with 5% CO₂.
4)After approximately 24–36 hours, replace the medium or passage the cells to remove non-adherent dead cells.


Subculturing procedure
1)When the cell density reaches the appropriate confluency for passaging, wash the cells with PBS, then add 1 mL trypsin to detach the cells. When more than 80% of the cells detach upon gently tapping the culture flask, add complete culture medium to terminate digestion. Gently pipette to obtain a single-cell suspension, transfer to a 15 mL centrifuge tube, and centrifuge at 1000 rpm for 5 minutes.

2)Discard supernatant after centrifugation. Resuspend cells in fresh medium to a single-cell suspension and transfer to a new culture flask for continued growth.


Cell Freezing
After trypsinization and centrifugation of cells from each T75 flask or 10 cm culture dish, discard the supernatant. Add 2 mL of cryopreservation medium (90% FBS + 10% DMSO), gently resuspend thoroughly, and aliquot into two cryovials. Immediately place the cryovials into a controlled-rate freezing container (e.g., Nalgene 5100-0001), fill with isopropanol to the indicated level, and store at −80 °C. After 24 hours, transfer the cryovials to liquid nitrogen for long-term storage.

Related products

We Are Pleased to Announce: Global Commercial Licensing Rights for Jurkat E6.1, CHO-K1, HEK293, THP-1 and RAJI Cell Lines Officially Secured.

Explore